ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics

Arteaga, Carlos L., Engelman, Jeffrey A.·2014·Cancer Cell

DOI 10.1016/j.ccr.2014.02.025

Cited by (999)

Items 701–800 of 999

Utility of FRET in studies of membrane protein oligomerization: The concept of the effective dissociation constant
Daniel M. McKenzie, Daniel Wirth, Taras V. Pogorelov, Kalina A. Hristova · 2023 · Biophysical Journal
Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5
Jessica Trammel, Oluwamuyiwa T. Amusan, Alison Hultgren, Gaurav Raikhy, J. Bodily · 2023 · Virology
Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation
Ratna Dini Haryuni, Satoko Watabe, Asako Yamaguchi, Yayoi Fukushi, Tomohiro Tanaka, Yuki Kawasaki, Yue Zhou, Satoru Yokoyama, Hiroaki Sakurai · 2019 · Biochemical and Biophysical Research Communications
Attenuation of epidermal growth factor (EGF) signaling by growth hormone (GH)
Lorena González, Johanna Gabriela Miquet, Pablo E Irene, Ma Eugenia Díaz, Soledad Paola Rossi, Ana I. Sotelo, Mónica Beatriz Frungieri, Cristal M. Hill, Andrzej Bartke, Daniel Turyn · 2017 · Journal of Endocrinology
Surviving Cancer without a Broken Heart
Oren Caspi, Doron Aronson · 2019 · Rambam Maimonides Medical Journal
Structural determinants for membrane binding of the EGFR juxtamembrane domain
Ziwei Wu, Ling Li, Lina Zhu, Runhan Wang, Yingkui Dong, Yaoyao Zhang, Yujuan Wang, Junfeng Wang, Lei Zhu · 2024 · FEBS Letters
HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma
Victoria M. Ettorre, Luca Palmieri, Valentino Clemente, Alessandro Davide Santin · 2025 · Cells
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
Sara García‐Alonso, Inés Romero-Pérez, Lucía Gandullo‐Sánchez, Luís Miguel Chinchilla-Tábora, Alberto Ocaña, Juan Carlos Montero, Atanasio Pandiella · 2021 · Journal of Experimental & Clinical Cancer Research
Role and mechanism of NCAPD3 in promoting malignant behaviors in gastric cancer
Suyun Zhang, Qiong Luo, Lirong Xiao, Fan Yang, Jian Zhu, Xiangqi Chen, Sheng Yang · 2024 · Frontiers in Pharmacology
NoxO1 regulates EGFR signaling by its interaction with Erbin
Maureen Hebchen, Tim Schader, Manuela Spaeth, Niklas Müller, Johannes Graumann, Katrin Schröder · 2024 · Redox Biology
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial
Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Nikolaj Dybowski, Sarah Elschenbroich, Martin Klammer, Adele R. Blackler, Wei‐Li Liao et al. · 2019 · PLoS ONE
Normal vitreous promotes angiogenesi via the epidermal growth factor receptor
Mengling You, Xiaobo Xia, Haibo Li, Jiayu Wu, Rong Rong, Zhou Zeng, Kun Xiong, Jufang Huang, Luosheng Tang, Hetian Lei et al. · 2020 · The FASEB Journal
Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice
Sreeram Vallabhaneni, Jian Liu, Marion Morel, Jixin Wang, Francesco John DeMayo, Weiwen Long · 2021 · Molecular Oncology
An effective strategy for ligand-mediated pulldown of the HER2/HER3/NRG1β heterocomplex and cryo-EM structure determination at low sample concentrations
Raphael Trenker, Devan C. Diwanji, Kliment A. Verba, Natalia Jura · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients
Eloísa Toscan Massignam, Cristine Dieter, Taís Silveira Assmann, Guilherme Coutinho Kullmann Duarte, Andréa Carla Bauer, Luís Henrique Santos Canani, Daisy Crispim · 2022 · Microvascular Research
A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA
Rebecca C. Allsopp, Karen Page, Bana Ambasager, Marc K. Wadsley, Emmanuel Acheampong, Tumisang Ntereke, Qi Jin Guo, Gurdeep Matharu Lall, Kelly L. T. Gleason, Evie Wren et al. · 2023 · Clinical Chemistry
Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer
Feng Jin, Xiaochen Ni, Shilong Yu, Xiaomin Jiang, Jun Ying Zhou, Defang Mao, Yanqing Liu, Feng Wu · 2023 · European journal of medical research
SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors
Daoshun Qu, Aixia Yan, J. S. Zhang · 2017 · SAR and QSAR in environmental research
1H, 13C and 15N assignments of the C-terminal intrinsically disordered cytosolic fragment of the receptor tyrosine kinase ErbB2
Yinghui Wang, Louise Pinet, Nadine Assrir, Latifa Elantak, Françoise Guerlesquin, Ali Badache, Ewen Lescop, Carine van Heijenoort · 2017 · Biomolecular NMR Assignments
Signal-dependent regulation of early-response genes and cell cycle: a quantitative view
Hiroaki Imoto, Mariko Okada · 2019 · Current Opinion in Systems Biology
Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases
Marika K.A. Koivu, Deepankar Chakroborty, Mahlet Z. Tamirat, Mark S. Johnson, Kari J. Kurppa, Klaus Elenius · 2020 · Molecular Cancer Therapeutics
EGFR (ErbB) Signaling Pathways in Pancreatic Cancer Pathogenesis
Monique Williams, Gwen Alyce Lomberk, Raul A. Urrutia · 2018 · Springer eBooks
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Mahlet Z. Tamirat, Kari J. Kurppa, Klaus Elenius, Mark S. Johnson · 2020 · Journal of Visualized Experiments
Drug-Resistant Brain Metastases: A Role for Pharmacology, Tumor Evolution, and Too-Late Therapy
Thomas P. Stricker, Carlos L. Arteaga · 2015 · Cancer Discovery
Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside
Gabriela Krämer-Marek, Wim J.G. Oyen · 2016 · Journal of Nuclear Medicine
Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum
Leandro Salati D'Abronzo, Chong-xian Pan, P. Ghosh · 2017 · Methods in molecular biology
Model‐Based Design of a Decision Tree for Treating HER2+ Cancers Based on Genetic and Protein Biomarkers
Kirouac, DC, Lahdenranta, J, Du, J, Yarar, D, Onsum, MD, Nielsen, UB, McDonagh, CF · 2015 · CPT: Pharmacometrics & Systems Pharmacology
Interobserver variability in her2 immunohistochemistry analysis and its clinical implications with the advent of the HER2-low category
Ana Catharina Joaquim, Lucas Kliemann Bazzaneze, Ana Paula Percicote, Ana Paula Martins Sebastião · 2025 · Surgical and Experimental Pathology
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer
Amanda B. Hesterberg, Hong Yuen Wong, Jorgen Jackson, Monika Antunovic, Brenda L. Rios, Evan Watkins, Riley E. Bergman, Brad A. Davidson, Sarah E. Ginther, Diana K. Graves et al. · 2025 · JCI Insight
Evidence for Unified Assessment Criteria of HER2 Immunohistochemistry in Colorectal Carcinoma
Mark Gordon Evans, Harris Benjamin Krause, Joanne Xiu, Andrew Elliott, Emil Lou, Hassan Ghani, Rhonda K. Yantiss, Monica Tulia Garcia-Buitrago, Yuki Matsubara, Yoshiaki Nakamura et al. · 2024 · Modern Pathology
Study of Azobenzene-modified Black Phosphorus for Potential Tumor Therapy
Zheng Dong, Wenxi Li, Junchuan Liang, Xue‐Ping Wang, Maokai Yu, Huaizhu Wang, Xiuxiu Wang, Jing Zhao, Zhong Jin, Jing Ma · 2024 · ACS Applied Materials & Interfaces
AKT Isoforms in the Immune Response in Cancer
Zayd Ahmad, Payaningal R. Somanath · 2022 · Current topics in microbiology and immunology
Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance
Manal M. Sami, MAHMOUD H. SHERIEF, Taghrid Bahig El-Abaseri, Ahmed I. El‐Sakka, Ahmed Taher El-Serafi · 2023 · Urologia Journal
Nanoplatform-based analysis for the detection of HER3 and HER4 for gastric cancer diagnosis
Damaris‐Cristina Gheorghe, Raluca‐Ioana Stefan‐van Staden, Ruxandra‐Maria Ilie‐Mihai, Paula Sfîrloagă · 2023 · Nanotechnology
HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies
Yunhe Xie, Jiarong Ye, Hongliang Luo · 2023 · OncoTargets and Therapy
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer
Jun Wen, Wenxing Cui, Xiaoyan Yin, Yu Chen, Ailing Liu, Qian Wang, Xiangjiao Meng · 2025 · Cancer Biology and Medicine
Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer
Rossella Martinello, Andrea Milani, Elena Geuna, G Zucchini, Caterina Aversa, Annamaria Nuzzo, Filippo Montemurro · 2016 · Expert Opinion on Investigational Drugs
Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?
Gilda Schmidt, Erich‐Franz Solomayer, Rainer Maria Bohle, Christoph Gerlinger, Julia Caroline Radosa, Jan Endrikat, Mariz Kasoha · 2020 · Journal of Cancer Research and Clinical Oncology
Gene expression dynamic analysis reveals co-activation of Sonic Hedgehog and epidermal growth factor followed by dynamic silencing
Vahed Maroufy, Pankil Shah, Arvand Asghari, Nan Deng, Rosemarie N.U. Le, Juan Camilo Ramírez, Ashraf S. Yaseen, Wenjin Jim Zheng, Michihisa Umetani, Hulin Wu · 2020 · Oncotarget
The impact of EGFR gene polymorphisms on the response and toxicity derived from neoadjuvant chemotherapy for breast cancer
Yan Wang, Ziping Wu, Liheng Zhou, Jinglu Lu, Yaohui Wang, Yanping Lin, Shuguang Xu, Yumei Ye, Jing Peng, Jie Zhang et al. · 2020 · Gland Surgery
RNA binding protein CUGBP1 mediates the liver metastasis of colorectal cancer by regulating the ErbB signal pathway
Zhipeng Qi, Zhanghan Chen, Dong-Li He, Shi‐Lun Cai, Bing Li, Di Sun, Zhen‐Tao Lv, En‐Pan Xu, Qiang Shi, Yunshi Zhong et al. · 2021 · Translational Cancer Research
PhosphoFlowSeq – A High-throughput Kinase Activity Assay for Screening Drug Resistance Mutations in EGFR
Anja Wagner, Magdalena Teufl, Lukáš Gold, Manfred Lehner, Christian Obinger, Peter Sykacek, Michael W. Traxlmayr · 2021 · Journal of Molecular Biology
Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR
Carolina Mantilla Rojas, Michael P. McGill, Anna C. Salvador, David J. Bautz, David W. Threadgill · 2021 · PLoS Genetics
An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations
Deepankar Chakroborty, Veera K. Ojala, Anna M. Knittle, Jasmin Drexler, Mahlet Z. Tamirat, Regina Ruzicka, Karin Bosch, Johanna Woertl, Susanne Schmittner, Laura L. Elo et al. · 2022 · Cancer Research Communications
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
Carmen Miano, Donatella Romaniello, Martina Mazzeschi, Alessandra Morselli, Silvia Da Pra, Francesca Sacchi, Chiara Bongiovanni, Michela Sgarzi, Elvira Pantano, Mattia Lauriola et al. · 2022 · Frontiers in Oncology
ERK‑mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells
Ratna Dini Haryuni, Tomohiro Tanaka, Yue Zhou, Satoru Yokoyama, Hiroaki Sakurai · 2020 · Oncology Letters
Molecular Targeted Therapy: Novel Therapeutic Approach for Head and Neck Cancer
Swatantra Shrivastava, Ravleen Nagi, Saurabh Sharma, Sajid Ahmed Rasul Sanadi, Elbadri Taha Dafallah, Akshay Ragit · 2020 · Therapeutic Delivery
Digital gene expression profiling analysis of childhood acute lymphoblastic leukemia
Mingyi Zhao, Yan Hui Yu, Min Xie, Minghua Yang, Shan Zhu, LIANG-CHUN YANG, Rui Kang, Daolin Tang, Lingling Zhao, Lizhi Cao · 2016 · Molecular Medicine Reports
Integrative multi-omics analysis reveal novel therapeutic targets for glioblastoma
Junhong Li, Yunbo Yuan, Yuze He, Zhihao Wang, Siliang Chen, Wenhao Li, Hao Ren, Yuhang Ou, Yunhui Zeng, Wanchun Yang et al. · 2025 · International Journal of Surgery
Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts
Luca Palmieri, Stefania Bellone, Cem Demirkiran, Tobias M.P. Hartwich, Namrata Sethi, Victoria M. Ettorre, Sarah Ottum, Michelle Greenman, Natália Buza, Pei Hui et al. · 2026 · Gynecologic Oncology
UPLC-Q-Exactive Orbitrap-MS and network pharmacology for deciphering the active compounds and mechanisms of stir-fried Raphani Semen in treating functional dyspepsia
Zhuang Miao, Xinyue Yu, Lizhen Zhang, Liqiao Zhu, Huagang Sheng · 2024 · Technology and Health Care
Novel 2‐Alkoxy‐3‐Cyanopyridine Derivatives as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, and In Silico Investigations
Ibtissem Kadi, Gökçe Seyhan, Zineddine Zebbiche, Suat Sarı, Burak Barut, Taoues Boumoud, Arif Mermer, Houssem Boulebd · 2025 · Chemistry & Biodiversity
STAT3‐mediated gene expression in colorectal cancer cells‐derived cancer stem‐like tumorspheres
Hua‐Ching Lin, Ai‐Sheng Ho, Hsin‐Hung Huang, Bi‐Ling Yang, Bin‐Bin Shih, Hsin‐Chi Lin, Chun Yeh, Chung‐Te Hsu, Chun‐Chia Cheng · 2020 · Advances in digestive medicine
EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus
Paul M. Gallo, Robert W. Chain, Jun Xu, Leah M. Whiteman, Annette Palladino, Roberto Caricchio, Patrícia Costa‐Reis, Kathleen E. Sullivan, Stefania Gallucci · 2024 · International Immunopharmacology
Pt( iv ) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116
Zhong‐Ying Ma, Xiaojing Ding, Zhen-Zhen Zhu, Qian Chen, Dong-Bo Wang, Xin Qiao, Jing‐Yuan Xu · 2024 · RSC Medicinal Chemistry
BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer
Shu-Liang Li, Pei‐Yao Wang, Yang-Pu Jia, Zhao‐Xiong Zhang, Hao-Yu He, Peng-Yu Chen, Xin Liu, Bang Liu, Li Lü, Weihua Fu · 2024 · World Journal of Gastrointestinal Oncology
6-C-methylquercetin in Baeckea frutescens exerts anti-prostate cancer effect via ErbB/PI3K/AKT pathway
Beixi Jia, Mengyao Zhang, Xinyue Jiang, Siyuan Zhou, Ke Han, Ruyi Deng, Haixia Cai, Yuefeng Bi · 2025 · Phytomedicine
Reverse engineering of triple-negative breast cancer cells for targeted treatment
Lena Blümel, Marie‐Kristin von Wahlde, Joke Tio, Ludwig Kiesel, Christof Bernemann · 2017 · Maturitas
Induction of apically mistrafficked epiregulin disrupts epithelial polarity via aberrant EGFR signaling
Bhuminder Singh, Galina T. Bogatcheva, Evan Krystofiak, Eliot T. McKinley, Salisha Hill, Kristie Lindsey Rose, James N. Higginbotham, Robert J. Coffey · 2021 · Journal of Cell Science
Targeting RPS6K1 for Refractory Breast Cancer Therapy
Jayalakshmi Sridhar, Rajesh Komati, Satyendra Kumar · 2022 · Exon Publications eBooks
COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma
Shiqing Wang, Yuxin Liu, Siyu Li, Yanan Chen, Yanhua Liu, Jie Yan, Jiayi Wu, Jia Li, Longlong Wang, Rong Xiang et al. · 2022 · Molecular Cancer Research
Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma
Esther Baranov, Jonathan Andrew Nowak · 2023 · Surgical pathology clinics
Regulation of EGFR surface levels by COPII-dependent trafficking
Hesso Farhan · 2016 · The Journal of Cell Biology
Multidrug resistance and the prospects of combination therapy
A. Balakrishna, G. Sravya, Tammineni Venkata Surendra, C. Suresh Reddy, Grigory V. Zyryanov, Nemallapudi Bakthavatchala Reddy · 2020 · Elsevier eBooks
Procyanidins in the Onset and Progression of Colorectal Cancer
Wei Zhu, Gerardo Guillermo Mackenzie, Patricia I. Oteiza · 2023 · Wiley eBooks
Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation
Raphael Trenker, Devan C. Diwanji, Tanner Bingham, Kliment A. Verba, Natalia Jura · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E. Chaft, Filiz Öezkan, Mark G. Kris, Paul A. Bunn, Ignacio Ivan Wistuba, David J. Kwiatkowski, Dwight Hall Owen, Yan Tang, Bruce Evan Johnson, Jay M. Lee et al. · 2023 · Nature Medicine
Radiolabeled HER2-targeted molecular probes in breast cancer imaging: current knowledge and future prospective
Fatemeh Movahed, Ouldouz Navaei, Shiva Taghlidi, Maryam Nurzadeh, Maryam Eslami gharaati, Maryam Rabiei · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
Hanane Horita, Yosuke Tsukiboshi, Kenichi Ogata, Aya Ogata, Hisaka Kurita, Shuji Yamashita, Hirotaka Yamashita, Naoki Inagaki, Hyogo Horiguchi, Hiroki Yoshioka · 2025 · Plants
Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer
Jaekwang Jeong, Kwangmin Yoo, Jong Won Lee, Jae Hun Shin, Jungmin Choi, John J. Wysolmerski · 2025 · Breast Cancer Research
Immunohistochemical Profiling of EGFR in Triple-Negative Breast Cancer: Diagnostic Utility and Prognostic Impact
Noura A. A. Ebrahim, Nancy H Amin, Mustafa A. Hussein · 2025 · Indian Journal of Gynecologic Oncology
Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis
Y C Chen, Yanjun Du, Juan Ni, Dong Wang, Ping Zhan, Yong Song, Hedong Han, Tangfeng Lv · 2025 · Therapeutic Advances in Medical Oncology
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
Yuwei Li, Kaiyan Chen, Hui Li, Yun Fan · 2026 · Cancer Treatment Reviews
Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models
Ulrich H. Weidle, Fabian Birzele · 2021 · Cancer Diagnosis & Prognosis
A Novel TNFSF‐Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower‐Grade Glioma
Rui Tao, Qi Liu, Ruoyu Huang, Kuanyu Wang, Zhiyan Sun, Pei Yang, Jiangfei Wang · 2022 · BioMed Research International
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer
Inés Romero-Pérez, Elena Dı́az-Rodrı́guez, Laura Sánchez-Díaz, Juan Carlos Montero, Atanasio Pandiella · 2024 · Oncogenesis
PlexinD1 is a driver and a therapeutic target in advanced prostate cancer
Jing Wei, Jing Wang, Wen Guan, Jingjing Li, Tianjie Pu, Eva Corey, Tzu-Ping Lin, Allen C. Gao, Boyang Jason Wu · 2025 · EMBO Molecular Medicine
Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors
Leslie Cuellar-Vite, Elyse M. Donaubauer, Kristen L. Weber-Bonk, Jessica R. Bobbitt, Natasha N. Ingles, Taylor L. Brzozowski, Fadi W. Abdul‐Karim, Christine Noga Booth, Ruth A. Keri · 2025 · Molecular Cancer Research
The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression
Xiaoyue He, Xiaohong Xia, Ziying Lei, Mengfan Tang, Jiangyu Zhang, Yuning Liao, Hongbiao Huang · 2025 · Neoplasia
NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition
Wei Zhang, Jiaqing Lang, Sorayut Chattrakarn, Chun Wai Wong, Shi-Yang Li, Karmern Kan, Hongcai Liu, Wenchao Gu, Jingwei Zhang, Jukka K. Westermarck et al. · 2025 · Oncogene
Intermediate Conductance Calcium‐Dependent Potassium Channel (K Ca 3.1) Interacting Proteins Using Turboid‐Based Proximity Labeling Technology: Insights Into Interactome and Related Signaling Pathways in Pancreatic Tumors
Veronica Carpanese, Soha Sadeghi, Luca Matteo Todesca, Ildikò Szabó, Vanessa Checchetto · 2025 · Journal of Cellular Physiology
Membrane domain formation—a key factor for targeted intracellular drug delivery
DuÅ¡an Popov-ÄŒeleketiÄ‡, Paul M.P. van Bergen en Henegouwen · 2014 · Frontiers in Physiology
A Computational Methodology to Overcome the Challenges Associated With the Search for Specific Enzyme Targets to Develop Drugs Against Leishmania major
Larissa Catharina, Carlyle Ribeiro Lima, Alexander Franca, Ana Carolina Ramos Guimarães, Marcelo Alves-Ferreira, Pierre Tufféry, Philippe Derreumaux, Nicolas Carels · 2017 · Bioinformatics and Biology Insights
Dynamics fingerprints of active conformers of epidermal growth factor receptor kinase
German Patricio Barletta, Marcia Anahí Hasenahuer, Marı́a Silvina Fornasari, Gustavo D. Parisi, Sebastian Fernández-Alberti · 2018 · Journal of Computational Chemistry
The Role of HER2 Testing in Advanced Colorectal Cancer
Rutika Jitesh Mehta · 2018 · Current Colorectal Cancer Reports
Etiologic Role of Kinases in the Progression of Human Cancers and Its Targeting Strategies
Sanjoy Das, Bireswar Bhattacharya, Biplajit Das, Bibek Sinha, Taison Jamatia, Kishan Paul · 2019 · Indian Journal of Surgical Oncology
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
Richard Lee Cullum, Lauren M. Lucas, Jared I. Senfeld, John Tyler Piazza, Logan T. Neel, Kanupriya Whig, Ling Zhai, Mackenzie H. Harris, Cristina C. Rael, Darby C. Taylor et al. · 2020 · PLoS ONE
A Brief Overview and Update on Major Molecular Genomic Alterations in Solid, Bone and Soft Tissue Tumors, and Hematopoietic As Well As Lymphoid Malignancies
Wei Zhang, JinJuan Yao, Minghao Zhong, Yaxia Zhang, Xiaoling Guo, Huan‐You Wang · 2021 · Archives of Pathology & Laboratory Medicine
Photon‐Induced Near‐Field Electron Microscopy of Eukaryotic Cells
Mohammed Kaplan, Byung‐Kuk Yoo, Jau Tang, Tony E. Karam, Bolin Liao, Devdoot S. Majumdar, David Baltimore, Grant J. Jensen, Ahmed H. Zewail · 2017 · Angewandte Chemie
HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer
Xuli Yang, Tao Chen, Jie Hong Hu, Jian Wang, Dong Yang · 2022 · Molecular Therapy — Oncolytics
Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2
Chinmoy Ghosh, Yanli Xing, Jinyang Cai, Yue Sun · 2023 · Biochemistry and Biophysics Reports
Colorectal cancer: understanding of disease
Lucy Mohapatra, Alok Shiomurti Tripathi, Deepak Kumar Mishra, Mohammad Yasir, Rahul Kumar Maurya, Bhupendra Gopalbhai Prajapati, Alka · 2024 · Elsevier eBooks
Current Perspective and Treatment Strategies in Targeted Therapy for Colorectal Cancer
Pramod Kumar Maurya, Ashutosh Mani · 2024 · Clinical Cancer Drugs
Inhibition of human epidermal growth factor receptor-2 protein by some alkaloid inhibitors
Leila Razavi, ‪Heidar Raissi · 2024 · Journal of Molecular Liquids
Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells
Su-Jin Kim, Angela KJ Park, Jeonghee Cho · 2018 · Biochemical and Biophysical Research Communications
Exploring the stochastic dynamics of correlated movement of receptor proteins in plasma membranes in vivo
Jung Yaw Huang, Chien Yu Lin · 2015 · The Journal of Chemical Physics
RETRACTED ARTICLE: Diagnostic and prognostic potentials of KLF6 and HER3 expression alterations in cutaneous malignant melanoma
Ali Ebrahimi, Seyed Mohamad Hossein Tabatabaei Nodushan, Alireza Mousavian, Aram Mokarizadeh, Mehdi Abbasi, Emad Yahaghi, Seyed Mohammad Rasaei · 2015 · Tumor Biology · Retracted
Biology and Genetics of Breast Cancer
Ayse Lale Dogan · 2015 · Springer eBooks
Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC
Damian Tobias Rieke, Ulrich Keilholz · 2016 · Recent results in cancer research/Recent Results in Cancer Research
Bedeutung der ERBB-Rezeptorfamilie beim Urothelkarzinom der Harnblase: mRNA-Expression und prognostische Relevanz
Philipp Erben, Felix Wezel, Ralph Markus Wirtz, Thomas Martini, Doron Stein, Cleo-Aaron Weis, Arndt Hartmann, Christian Bolenz · 2017 · Aktuelle Urologie